Sunny Pharmtech Inc. (TPEX:6676)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.20
-0.20 (-1.61%)
Aug 4, 2026, 1:59 PM CST

Sunny Pharmtech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
47.77138.02270.56222.63229
Short-Term Investments
---48.5112.5
Cash & Short-Term Investments
47.77138.02270.56271.14241.5
Cash Growth
-65.39%-48.98%-0.21%12.27%-0.09%
Accounts Receivable
64.5649.3456.3528.7763.63
Other Receivables
0.672.260.81.787.17
Receivables
65.2351.657.1530.5570.8
Inventory
80.14123.4997.0471.9497.6
Prepaid Expenses
47.2148.6428.6521.7518.4
Other Current Assets
7.13.17.118.643.48
Total Current Assets
247.44364.86460.49413.98471.78
Property, Plant & Equipment
1,0031,0921,1561,102946.12
Long-Term Investments
59.75----
Goodwill
25.2425.2425.2425.2425.24
Other Intangible Assets
28.8135.9642.7755.251.42
Other Long-Term Assets
38.3469.227.9132.76100.16
Total Assets
1,4031,5871,7121,6301,595

Liabilities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
8.2816.8826.1312.3423.17
Accrued Expenses
40.0446.9230.4323.8121.9
Short-Term Debt
14320-19050
Current Portion of Long-Term Debt
20.7520.7511.199.4420.09
Current Portion of Leases
4.144.173.943.162.79
Current Unearned Revenue
30.6432.519.1912.4810.87
Other Current Liabilities
25.2223.7320.9529.0336.89
Total Current Liabilities
272.06164.94111.83280.25165.7
Long-Term Debt
276.31297.06333.81327.24264.44
Long-Term Leases
40.1744.3142.4932.8628.98
Long-Term Unearned Revenue
52.0327.1317.0712.741.46
Other Long-Term Liabilities
7.247.247.247.247.68
Total Liabilities
647.82540.68512.44660.32468.26

Shareholders' Equity

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,4881,4881,4851,3851,385
Additional Paid-In Capital
23.1721.69209.5316.9169.06
Retained Earnings
-765.01-462.96-496.17-432.85-427.84
Comprehensive Income & Other
8.420.411.32--
Shareholders' Equity
754.951,0471,200969.31,126
Total Liabilities & Equity
1,4031,5871,7121,6301,595

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
484.37386.29391.43562.69366.3
Net Cash (Debt)
-436.61-248.27-120.87-291.55-124.8
Net Cash Growth
-----
Net Cash Per Share
-2.93-1.67-0.85-2.10-0.93
Filing Date Shares Outstanding
148.84148.76148.53138.53138.53
Total Common Shares Outstanding
148.84148.76148.53138.53138.53
Working Capital
-24.62199.92348.66133.74306.08
Book Value Per Share
5.077.048.087.008.13
Tangible Book Value
700.9985.491,132888.861,050
Tangible Book Value Per Share
4.716.627.626.427.58
Buildings
867.78856.04847.93777.39702.81
Machinery
871.52856.32822.27587.06512.13
Construction In Progress
0.142.694.44162.9164.94